Aplasia is a medical term meaning an organ, tissue, or body part failed to develop normally, usually during embryonic growth. In some cases, a basic structure began forming and then stopped. In others, the body part is entirely missing. Aplasia isn’t a single disease but rather a description that applies across many different conditions, from missing blood cells to absent patches of skin to underdeveloped lungs.
How Aplasia Differs From Related Terms
Aplasia sits on a spectrum of developmental problems, and the terminology can be confusing because doctors sometimes use these words interchangeably. The key distinctions come down to how much development actually occurred.
Agenesis means a body part never formed at all. No trace of the organ exists. Aplasia means a primitive, basic structure started to develop but then stopped before it became functional. Hypoplasia means the organ did form but is underdeveloped or smaller than it should be. Dysplasia, which you may also encounter, means a body part developed abnormally in structure rather than simply failing to appear.
Pulmonary aplasia is a useful example of how these terms relate. With lung agenesis, there is no lung tissue whatsoever. With pulmonary aplasia, a rudimentary lung structure exists but can’t do the work of breathing. With hypoplasia, the lung is present and partially functional but undersized. These aren’t separate diseases so much as points along the same continuum of incomplete development.
Aplastic Anemia: The Most Common Use
When most people encounter the word “aplasia” in a medical setting, it’s in the context of aplastic anemia, a condition where bone marrow fails to produce enough blood cells. The marrow, which normally acts as a factory for red cells, white cells, and platelets, becomes severely depleted. This leads to a drop in all three cell types at once.
The underlying problem is damage to the stem cells that live inside bone marrow. These are the parent cells responsible for generating every blood cell in your body. In aplastic anemia, your immune system can mistakenly attack and destroy these stem cells. Immune cells release signals that trigger the stem cells to self-destruct, gradually hollowing out the marrow. Genetic factors also play a role: some people have stem cells with shortened protective caps on their chromosomes (called telomeres), making those cells more vulnerable to damage and less able to replicate.
External triggers can set this process in motion. Radiation therapy and chemotherapy, while targeting cancer cells, can damage marrow stem cells as a side effect. Toxic chemicals like benzene (found in gasoline) and certain pesticides have been linked to aplastic anemia. Specific medications are known triggers as well, including chloramphenicol (an antibiotic) and gold compounds once used for rheumatoid arthritis. In many cases, though, no clear cause is ever identified.
Severe aplastic anemia is diagnosed when bone marrow cellularity drops below 25%, meaning the marrow is more than three-quarters empty space where blood-producing cells should be. Patients typically have dangerously low counts across all blood cell types: very few infection-fighting white cells, minimal platelets for clotting, and not enough red cells to carry oxygen. Symptoms include profound fatigue, frequent infections, easy bruising, and shortness of breath.
Pure Red Cell Aplasia
A more targeted form of bone marrow aplasia affects only red blood cell production. In pure red cell aplasia, the marrow stops making red blood cells while continuing to produce white cells and platelets normally. This selectivity is what distinguishes it from full aplastic anemia.
Because only red cells are missing, the main consequence is anemia. People with this condition experience fatigue, weakness, pallor, reduced exercise tolerance, and sometimes heart palpitations or lightheadedness. Blood tests show low red cell counts with normal white cell and platelet numbers. A bone marrow biopsy reveals that the specific precursor cells responsible for becoming red blood cells are nearly absent (less than 1% of marrow cells), while everything else looks normal.
Aplasia of Organs and Limbs
Aplasia can affect virtually any body part during fetal development. These congenital forms are typically apparent at birth, though some go undetected for years.
Lung Aplasia
Unilateral lung aplasia, where one lung fails to develop, occurs in roughly 1 to 2 out of every 10,000 births. Some people born with only one functional lung remain completely asymptomatic, sometimes not receiving a diagnosis until adulthood when imaging is done for an unrelated reason. Others experience recurrent respiratory infections, wheezing, shortness of breath, or coughing up blood.
Which side is affected matters significantly. Right-sided lung aplasia carries a worse prognosis because the missing right lung causes greater shifting of the heart and central chest structures, distorting the airway. Left-sided aplasia tends to have better outcomes, with the remaining lung adapting more effectively. Several documented cases show people with unilateral lung aplasia surviving well into their 30s, 50s, and beyond with relatively normal lives. Bilateral lung aplasia, where both lungs fail to form, is incompatible with life.
Aplasia Cutis Congenita
This condition involves patches of missing skin at birth, most commonly on the scalp near the top of the head. It ranges widely in severity. Small, isolated defects typically heal well and carry a favorable prognosis. Larger defects pose serious risks, including life-threatening hemorrhage and recurrent infections. Some cases require multiple surgical procedures, including skin grafts or flap procedures, to achieve closure. While aplasia cutis congenita usually appears as an isolated finding, it can occasionally occur alongside genetic syndromes or other congenital abnormalities.
Radial Aplasia
Aplasia of the radius, the bone on the thumb side of the forearm, can cause significant limb differences. Arms may be unequal in length, forearm rotation can be limited, and the thumb may be absent or malformed. Radial aplasia is a hallmark of Holt-Oram syndrome, a genetic condition caused by mutations in a gene called TBX5. In this syndrome, upper-limb abnormalities are usually present on both sides but asymmetric, ranging from subtle thumb abnormalities to significant forearm shortening. More than 70% of people meeting the clinical criteria for Holt-Oram syndrome carry an identifiable TBX5 mutation. The syndrome also involves heart defects, particularly problems with the walls separating the heart chambers and with the electrical conduction system.
Treatment for Bone Marrow Aplasia
For severe aplastic anemia, treatment depends largely on your age and whether a suitable bone marrow donor is available. A bone marrow transplant from a matched sibling donor is the most definitive treatment, essentially replacing the damaged marrow with healthy stem cells from a donor.
For patients who aren’t candidates for a transplant, the standard approach uses immunosuppressive therapy to stop the immune system from attacking the remaining marrow stem cells. This combination therapy produces a blood count recovery in 60 to 70% of patients, with five-year survival rates ranging from 60 to 85%. A clinical trial comparing immunosuppressive combinations found that the most effective regimen achieved an overall response rate of 74%, with 57% of patients reaching complete recovery.
Long-Term Outlook
The prognosis for aplasia varies enormously depending on which tissue is affected and how severe the deficiency is. For severe aplastic anemia, recent long-term data is encouraging. Patients who survive the first year after treatment, whether transplant or immunosuppressive therapy, can generally expect to live beyond five and ten years. Those who reach the five-year mark now show survival rates comparable to the general population. The greatest risk of complications falls between years one and five, including incomplete treatment response or graft-related issues. After that window, patients who have responded well can reasonably be considered cured.
For congenital forms of aplasia, outcomes hinge on which organ is involved, how much function remains, and whether other birth defects are present. A person born with left-sided lung aplasia and no other abnormalities may live a full life with minimal limitations. Someone with extensive skin aplasia or bilateral organ aplasia faces a fundamentally different situation. The common thread is that aplasia describes a gap in development, and the consequences depend entirely on what’s missing and how critical that missing piece is to daily function.